POST-THROMBOTIC SYNDROME
Clinical trials for POST-THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST-THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug may stop repeat blood clots
Disease control Recruiting nowThis study tests whether adding rosuvastatin (a cholesterol-lowering drug) to standard blood thinners can lower the risk of another blood clot in people who recently had a deep vein thrombosis or pulmonary embolism. About 2700 adults will receive either rosuvastatin or a placebo …
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated May 26, 2026 04:47 UTC
-
New device battles DVT: could it prevent lasting leg damage?
Disease control Recruiting nowThis study tests a device that physically removes blood clots from the leg veins (ClotTriever) against standard blood thinner medication alone. About 300 people with a recent, severe deep vein thrombosis (DVT) in one leg will be randomly assigned to one of the two treatments. The…
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated May 19, 2026 11:47 UTC